Minami Y, Taguchi M, Nanba R, Tsuto H, Yamamoto T, Ueda K, Tsushima T, Morihana T, Nagata K, Nakao K, Shimada K
Jpn J Antibiot. 1982 May;35(5):1308-21.
Experimental and clinical studies were carried out on cefmetazole (CMZ), a synthetic antibiotic of cephamycin group, and the following results were obtained. 1) The minimal inhibitory concentrations (MICs) of CMZ against Gram positive cocci (30 strains) isolated from the patients with oral infections showed slightly inferior to those of ABPC, CEZ, while MICs against Gram negative bacilli (166 strains) of CMZ exhibited stronger activity than ABPC, CEZ. 2) The mean serum concentration of CMZ at 60 minutes after drip infusion showed 65.6 micrograms/ml. The concentration of CMZ in oral tissues varied in 4--60% of serum level at 60 minutes after drip infusion. The concentration in pus showed 15.2 micrograms/g at 60 minutes after drip infusion. 3) CMZ was administered by the drip infusion to 22 patients with various infections in the oral surgical field. The efficacy rate was 90.9%. 4) No side effect was observed.
对头孢美唑(CMZ),一种头孢霉素类合成抗生素,进行了实验和临床研究,获得了以下结果。1)CMZ对从口腔感染患者分离出的革兰氏阳性球菌(30株)的最低抑菌浓度(MIC)略低于氨苄青霉素(ABPC)、头孢唑啉(CEZ),而CMZ对革兰氏阴性杆菌(166株)的MIC显示出比ABPC、CEZ更强的活性。2)滴注后60分钟时CMZ的平均血清浓度为65.6微克/毫升。滴注后60分钟时,CMZ在口腔组织中的浓度为血清水平的4% - 60%。滴注后60分钟时,脓液中的浓度为15.2微克/克。3)对22例口腔外科领域各种感染患者进行了CMZ滴注给药。有效率为90.9%。4)未观察到副作用。